港交所重磅期指即将上新！恒生生物科技指数涨超1%

Group 1 - The Hong Kong stock market saw a collective rise in key indices, with the Hang Seng Index and Hang Seng Tech Index both increasing by over 1%, while the Hang Seng Biotechnology Index, focused on innovative pharmaceuticals, rose by over 2% [1] - The largest ETF tracking the Hang Seng Biotechnology Index, the Hang Seng Medical ETF (159892), followed the index's upward trend, with companies such as 3SBio and Innovent Biologics leading the gains [1] - The Hang Seng Biotechnology Index, launched in 2019, reflects the overall performance of the biotechnology sector in the Hong Kong stock market, capturing the full industry chain performance by also considering upstream CXO companies [1] Group 2 - The Hong Kong Stock Exchange is set to launch futures for the Hang Seng Biotechnology Index, enhancing its expanding ecosystem of derivative products [1] - The new futures contract will begin trading on November 28, 2025, providing investors with precise risk management tools [1] - The Hang Seng Biotechnology Index will become the only index in the Hong Kong stock market with index futures in the pharmaceutical and healthcare sector [1]